| Name | HJM-561 |
|---|
| Description | HJM-561 is a potent, selective, orally bioavailable EGFR PROTAC. HJM-561 overcomes osimertinib (HY-15772)-resistant EGFR triple mutations and has anti-tumor activity[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C45H51ClN9O5P |
|---|---|
| Molecular Weight | 864.37 |